T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 2361-2366

  Becker, Jürgen C ^a   Pancook, James D ^a   Gillies, Stephen D ^b   Furukawa, Koichi ^c   Reisfeld, Ralph A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Fuji ImmunoPharmaceuticals Corp   (United States)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHIMERIC ANTIBODY; HYBRID PROTEIN; INTERLEUKIN 2 DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; IMMUNE RESPONSE; LIVER METASTASIS; LUNG METASTASIS; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHOCYTE DEPLETION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, SCID; RATS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0029890827     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.2361     Document Type: Article

References (13)

1. Talmage, D.W., J.A. Woolnough, H. Hemmingsen, L. Lopez, and K.J. Lafferty. 1977. Activation of cytotoxic T cells by non-stimulating tumor cells and spleen cell factor(s). Proc. Natl. Acad. Sci. USA. 74:4610-4614.
2. Schmidt-Wolf, G., and I.G.H. Schmidt-Wolf. 1995. Cytokines and clinical gene therapy. Eur. J. Immunol. 25:1137-1140.
3. Colombo, M.P., and G. Forni. 1994. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today. 15:48-51.
4. Maas, R.A., H.F.J. Dullens, and W.D. Otter. 1993. IL2 in cancer treatment. Cancer Immunol. Immunother. 36:141-148.
5. Gillies, S.D., E.B. Reilly, K.-M. Lo, and R.A. Reisfeld. 1992. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proc. Natl. Acad. Sci. USA. 89: 1428-1432.
6. Becker, J.C., J.D. Pancook, S.D. Gillies, J. Mendelsohn, and R.A. Reisfeld. 1996. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins. Proc. Natl. Acad. Sci. USA. In press.
7. Haraguchi, M., S. Yamashiro, A. Yamamoto, K. Furukawa, K. Takamiya, K.O. Lloyd, H. Shiku, and K. Furukawa. 1994. Isolation of GD3 synthase gene by expression cloning of GM3 α-2,8-sialtransferase cDNA using anti-GD2 monoclonal antibody. Proc. Natl. Acad. Sci. USA. 91:10455-10459.
8. Ledbetter, J.A., R.V. Rouse, H.S. Micklem, and L.A. Herzenberg. 1980. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. J. Exp. Med. 152:280-295.
9. Forni, G., G. Mirrella, A. Santoni, A. Modesti, and M. Forni. 1987. Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J. Immunol. 138:4033-4041.
10. Mackay, C.R. 1993. Immunological Memory. Adv. Immunol. 53:217-265.
11. Sprent, J. 1995. Professionals and amateurs. Curr. Biol. 5: 1095-1097.
12. Steinman, R.M. 1991. The dentritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-307.
13. Strobel, I., R. Rupec, A. Wollenberg, and T. Bieber. 1993. IL-2 receptor on human Langerhans cells lack the β-chain but mediates IL-2 dependent migration: evidence for a putative γ-chain? Arch. Dermatol. Res. 285:108.